Digital health and wearable device companies exist at an unusual regulatory intersection. A company building a cardiac arrhythmia detection algorithm embedded in a consumer smartwatch must simultaneously satisfy FDA's Software as a Medical Device (SaMD) Pre-Specifications (SPS) and Algorithm Change Protocol (ACP) documentation requirements, comply with Apple and Google app store medical device developer policies, coordinate real-world evidence collection from thousands of deployed devices, and manage patient enrollment for ongoing post-market performance studies.
For a 20-person digital health startup, that's a compliance stack that would challenge a team three times its size—and most founders don't realize the administrative scope until they're already deep into FDA interactions.
The SaMD Regulatory Documentation Problem
FDA's 2019 Digital Health Center of Excellence and its evolving SaMD framework under the Software Precertification Program have created significant documentation obligations for companies whose products qualify as regulated software. Under FDA's guidance on Software Functions Subject to 510(k) Requirements (2022), SaMD developers must maintain clinical validation documentation, cybersecurity risk management files, real-world performance data, and algorithm change documentation.
Unlike hardware devices, SaMD products evolve rapidly—software updates can be frequent, and each significant update must be evaluated against the device's approved specifications. Managing the documentation trail for a SaMD product over a 12-month deployment period can generate hundreds of records that require organized, version-controlled maintenance.
Virtual Assistant Functions for Digital Health Companies
FDA SaMD Documentation Coordination: The VA maintains the SaMD documentation library—clinical validation study reports, software development lifecycle (SDLC) records, algorithm performance summaries, cybersecurity vulnerability assessments, and Pre-Specifications documents. As the software evolves, the VA tracks documentation updates triggered by each algorithm change or feature release.
App Store Regulatory Compliance Tracking: Apple's App Store Review Guidelines (Guideline 5.2) and Google Play's Health and Medical Apps policies impose specific restrictions and requirements on medical-grade app submissions. The VA tracks compliance requirements for each platform, monitors for policy updates that affect the app's classification, and prepares compliance documentation packages for app store submissions.
Real-World Evidence Data Collection Coordination: Post-market SaMD performance studies require systematic collection of real-world device data from enrolled users. The VA coordinates data collection workflows—managing participant communication, tracking consent form status, coordinating with data science teams on data feed validation, and maintaining enrollment status dashboards.
Patient Enrollment Coordination: For companies running formal post-market clinical performance studies or registry programs, patient enrollment administration is a significant operational task. The VA manages enrollment pipelines—tracking screened vs. enrolled vs. withdrawn participants, coordinating with clinical sites for enrollment reporting, and preparing enrollment status updates for the clinical and regulatory teams.
Market Context
The digital health market reached $211 billion globally in 2023 according to the Digital Medicine Society (DiMe), with wearable health monitoring devices among the fastest-growing segments. Yet DiMe's 2024 survey of digital health companies found that regulatory and clinical compliance administration was the number one operational bottleneck cited by companies in the growth stage—outranking engineering talent and capital access.
FDA cleared 49 AI/ML-based medical devices in FY2023, each requiring ongoing SaMD documentation maintenance that most clearance recipients are unprepared to sustain administratively.
Find digital health and wearable device VA support at Stealth Agents to keep your SaMD documentation current and your real-world evidence program running.
Sources
- FDA Digital Health Center of Excellence, Software as a Medical Device Guidance, 2022
- Digital Medicine Society (DiMe) State of Digital Health Survey, 2024
- Apple App Store Review Guidelines, Medical Device App Policy, 2024
- FDA AI/ML-Based Software as a Medical Device Action Plan, 2023
- FDA Center for Devices and Radiological Health SaMD Cleared Devices Database, FY2023